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Abstract
Proton magnetic resonance spectroscopy (1H-MRS) has been used in a number of studies to noninvasively assess the temporal changes of
lactate in the activated human brain. However, the results have not been consistent. The aim of the present study was to test the sensitivity of
1H-MRS during functional experiments at the highest magnetic field currently available for human studies (7 T). Stability and reproducibility
of the measurements were evaluated from LCModel analysis of time series of spectra measured during a visual stimulation paradigm and by
examination of the difference between spectra obtained at rest and during activation. The sensitivity threshold to detect concentration changes
was 0.2 Amol/g for most of the quantified metabolites. The possible variations of metabolite concentrations during visual stimulation were
within the same range (F0.2 Amol/g). In addition, the influence of a small line-narrowing effect due to the blood oxygenation level-
dependent (BOLD) T2* changes on the estimated concentrations was simulated. Quantification of metabolites was, in general, not affected
beyond 1% by line-width changes within 0.5 Hz.
D 2006 Elsevier Inc. All rights reserved.
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Proton magnetic resonance spectroscopy (1H-MRS) has
emerged as a powerful tool to investigate the metabolism of
the human brain during activation. The detection of
functional changes of metabolite concentrations may help
to understand the metabolism that sustains the brain at work.
So far, single-voxel 1H-MRS as well as spectroscopic
imaging, generally performed at magnetic fields lower than
3 T, have been used with the goal of identifying variations
of metabolites during several kinds of brain activation
[1–11]. In particular, lactate (Lac) has been receiving special
attention, since the functional involvement of this metabo-
lite was firstly hypothesized after the study conducted in
1988 by Fox et al. [12], who found an uncoupling between0730-725X/$ – see front matter D 2006 Elsevier Inc. All rights reserved.
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Lactate, and not glucose, was later proposed by Pellerin
and Magistretti [13] as the main metabolic substrate for
activated neurons, in the framework of the so-called
astrocyte–neuron Lac shuttle. Lactate was reported by some
authors to increase during prolonged visual stimulations
[1,2,5], during a motor task [4] and during silent word
generation [7]; a decrease was also observed few seconds
after the presentation of an impulsive visual stimulation [6].
The results of these studies have been inconsistent thus far;
for example, long photic stimuli were reported to cause
either 50–60% [1,5] or 250% [2] increases in Lac
concentration. These discrepancies were probably due to
different experimental parameters adopted in the various
laboratories and to the fact that Lac is a low-concentration
metabolite (about 1 Amol/g) and therefore its reliable
detection in basal condition was not always possible. In
fact, the feasibility itself of detecting Lac changes has been
challenged by some authors: a high variability of the basalaging 24 (2006) 343–348
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not detect any reproducible time course between subjects.
More recently, Boucard et al. [8] did not observe any
significant alteration of the spectra during prolonged
stimulation; in their setup, the region of the spectrum around
1.33 ppm was indeed affected by unstable signals presum-
ably coming from lipids of the scalp. The authors concluded
that previous claims about Lac changes might have an
artefactual origin.
Optimizing the sensitivity and accuracy of the method-
ology for functional MRS studies is important not only
because metabolites are present in low concentration, but
also because concentration changes are expected to be
relatively small, since the brain metabolite concentrations
are likely to be homeostatically controlled in physiological
conditions. In this context, ultrahigh magnetic field systems
can help in obtaining robust and accurate time courses of
metabolites, due to the increased spectral dispersion and
signal-to-noise ratio (SNR) compared to lower fields [14].
In the present study we investigated the sensitivity of
single-voxel 1H-MRS at 7 T for functional applications,
with the purpose of establishing a threshold limit of
concentration changes that can be detected with statistical
certainty. A high number of metabolite concentrations was
quantified during a visual stimulation paradigm, similar to
the one previously used by Frahm et al. [5].
It has been previously reported that the blood oxygen-
ation level-dependent (BOLD) effect produces a small line-
narrowing (around 0.2–0.3 Hz) on the spectra at 4 T [15]. A
secondary aim of the study was to determine the influence
of the BOLD effect on the quantification of metabolites
obtained by LCModel [16] at 7 T.2. Methods
The measurements described herein were performed on a
7 T/90 cm magnet (Magnex Scientific, UK), interfaced to
Varian INOVA console. The system was equipped with a
head gradient coil (40 mT/m, 500 As rise time) and strong
custom-designed second-order shim coils (Magnex Scien-
tific) with the maximum strengths of XZ=5.8104 mT/
cm2, YZ =5.6104 mT/cm2, Z2=9.0104 mT/cm2,
2XY=2.8104 mT/cm2 and X2Y2=2.9104 mT/cm2
at a current of 4 A. All first- and second-order shim terms
were automatically adjusted using FASTMAP with EPI
readout [17,18]. In vivo 1H-NMR spectra were acquired
using ultrashort echo-time STEAM (TE=6 ms, TM=32 ms,
TR=5 s) optimized for applications in humans at ultrahigh
magnetic field [19]. A bdouble localizationQ was performed
with STEAM and four modules of outer volume saturation;
water signal was suppressed by VAPOR [20,21].
Two healthy volunteers gave informed consent according
to procedures approved by the institutional review board
and the FDA. Each subject was investigated twice during a
paradigm of visual activation, with the voxel of interest
(VOI=202020 mm3) positioned inside the visual cortexin one case and outside in the other (control conditions). The
stimulus, which was projected to a mirror fixed on the head
coil, consisted of a radial red/black checkerboard covering
the entire visual field and flickering at a frequency of 8 Hz.
A red cross in the middle of the image was used as fixation
point; in order to check their attentional status, the
volunteers were asked to press a button whenever the cross
in the fixation point changed orientation.
Initial fMRI sessions based on BOLD contrast were
performed before the spectroscopy studies in order to
identify the activated visual area. The parameters used were
single-shot gradient-echo echo planar imaging (GE-EPI), 16
sagittal slices, TE=22 ms, spatial resolution=2.52.5
2.5 mm3, TR=2.5 s; functional paradigm: eight trials of 10 s
ON+22.5 s OFF. Cross-correlation (cc) coefficients were
calculated pixelwise between a hemodynamic reference
waveform and the fMRI time series. Only pixels with
ccz0.3 were considered activated, and a cluster filter
(cluster size z6 contiguous pixels) was applied to produce
final activation maps.
The protocol of functional spectroscopy involved initial
32 scans at rest (black image) and four periods (64 scans
each, 5.3 min long) acquired in an interleaved manner
during conditions of visual stimulation ON and OFF, for a
total duration of about half an hour. This was a study
duration that ensured reasonable stability, attention and
comfort of the volunteer.
After having applied frequency and phase corrections
on single scans, nine spectra (32 scans each) were
obtained. These spectra were corrected for residual eddy
currents by using internal water reference and finally they
analyzed by LCModel [16]. The unsuppressed water signal
measured from the same VOI was used as an internal
reference for quantification assuming brain water content
of 80%. The LCModel basis set included the simulated
spectra of 21 metabolites and the spectrum of fast relaxing
macromolecules experimentally measured from the human
brain using an inversion-recovery experiment (TR=2 s,
IR=0.675 s) [21]. Those metabolites that were quantified
with Cramer–Rao lower bounds (CRLBs) N30% were
discarded for further analysis.
In order to test the influence of line-width changes
(resulting from the BOLD effect) on metabolite quantifica-
tion, FIDs were multiplied by exponential functions
corresponding to 0.1–0.5-Hz line broadening and then
fitted with LCModel. Appropriate white noise was added
back to FIDs to keep the noise level constant.3. Results
Spectra obtained during rest and stimulation conditions
from the same subject, with the voxel localized inside and
outside the visual cortex, are shown in Fig. 1. Shim-
ming resulted in water line widths around 13–14 Hz, with
concomitant creatine (Cr) line widths of 11–12 Hz. Spectra
were highly reproducible between different sessions and
Fig. 1. Spectra obtained at rest and during stimulation in a single subject, when theVOI (202020mm3) was located outside (A) and inside (B) the visual cortex.
The insets depict functional maps with the localization of the VOIs (GE-EPI, TE=22 ms, TR=2.4 s, spatial resolution 2.52.52.5 mm3; activated pixels
correspond to ccz0.3, cluster size z6 contiguous pixels). Differences between spectra obtained in the two conditions of rest and stimulation are also shown.
Spectroscopic parameters: STEAM, TE=6 ms, TM=32 ms, TR=5 s. Processing: frequency and phase corrections of individual scans, summation of 32 scans,
residual eddy currents correction, gaussian multiplication (r =0.0865 s), FFT and zero-order phase correction. No further postprocessing, such as water signal
removal and baseline correction, was performed. Spectra in A and B have the same vertical scale. The small narrow peaks at 2.0 and 3.0 ppm, visible in the
difference spectrum when the VOI was located inside the visual cortex, were ascribed to the BOLD effect.
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quence and efficient VAPOR water suppression resulted in
spectra with minimal distortions and a flat baseline in the
entire chemical shift range. Contamination by signals from
extracerebral lipids was not observed in spite of the
ultrashort TE of 6 ms.
The difference between spectra obtained at rest and
during stimulation (Fig. 1) revealed minimal residualsabove the noise level; when the voxel was located inside
the visual cortex (Fig. 1B), narrow small peaks (line width
around 6 Hz) were visible in the difference spectra at
the positions of the singlets of N-acetylaspartate (NAA)
(2.0 ppm) and Cr (3.0 ppm). This effect was not present
when the voxel was located outside the visual cortex
(Fig. 1A). With the achieved SNR, no other peaks were
evident in the difference spectra.
Table 1



















Asc 1.2 0.21 18 11 6 3.1
Asp 1.0 0.26 28 15 16 3.8
Cr 5.0 0.26 5 3 2 0.8
PCr 3.4 0.24 7 4 3 1.4
GABA 1.0 0.13 14 4 9 1.7
Glc 1.1 0.28 25 13 17 0.3
Gln 2.9 0.16 6 4 3 0.1
Glu 11.0 0.22 2 1 1 1.1
GSH 1.0 0.10 10 8 7 0.9
Ins 6.7 0.20 3 1 2 1.0
Lac 0.8 0.10 13 8 19 0.1
NAA 10.8 0.14 1 1 1 1.2
NAAG 1.4 0.11 8 3 5 0.4
PE 1.2 0.19 16 12 7 1.4
Scyllo 0.4 0.05 12 9 4 2.4
Tau 1.9 0.18 10 4 4 3.4
GPC+PCho 1.3 0.05 4 2 1 1.4
Values were calculated from all nine spectra obtained during each
functional study and by averaging the data from the two subjects. Voxel
OUT or IN means outside (control conditions) or inside the visual cortex.
The column relative to bSimulated BOLD effectQ indicates the estimated
artefactual concentration changes derived by LCModel at 0.4 Hz
line narrowing.
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phosphocreatine (PCr), glucose (Glc), glutamate (Glu),
glutamine (Gln), glutathione (GSH), inositol (Ins), Lac,
NAA, N-acetylaspartylglutamate (NAAG), g-aminobutyricFig. 2. Example of time courses of selected metabolites obtained by LCModel from
to visual stimulation), when the voxel was located outside (A) and inside (B) the
paradigm were within F0.2 Amol/g. Error bars indicated CRLB.acid (GABA), scyllo-inositol (Scyllo), taurine (Tau),
choline, and phosphorylethanolamine (PE) were quantified
by LCModel with CRLB b30% (Table 1), which corre-
sponded to CRLB below 0.2 Amol/g for most of the
quantified metabolites in each individual study. In partic-
ular, the average CRLB of lactate was ~0.1 Amol/g,
amounting to 10% of uncertainty. In order to assess the
reproducibility of the measurements, intrasubject variations
(expressed as S.D.) were calculated in control conditions,
that is when the voxel was located outside the visual
cortex. Concentration variations were always slightly lower
than the average CRLB for all metabolites (Table 1). No
discernible trend with time and stimulus onset was
observed (Fig. 2A). When the voxel was located inside
the visual cortex (Fig. 2B), the time courses obtained with
LCModel revealed that concentration changes of all
quantified metabolites were within F0.2 mol/g. Also in
this case, S.D.’s were lower than CRLB, except for lactate
whose S.D. was more than twofold higher than the S.D. in
control conditions (Table 1).
Simulations demonstrated that when applying line
broadening up to 0.5 Hz, estimates of all metabolite
concentrations were reproducible within the limit imposed
by the CRLB of the fit (Fig. 3). For most of the
quantified metabolites the estimated concentrations sys-
tematically decreased by almost 1% when increasing the
line width by 0.3–0.4 Hz, that is on the same order of the
expected line narrowing due to the BOLD effect at 7 T
(Table 1). Asc, Asp, Scyllo and Tau were slightly more
influenced by the introduced line narrowing (2–4%). In
contrast, quantifications of Glc (0.3%), Gln (0.1%) andthe same subject during the functional paradigm (shaded areas correspond
visual cortex. Changes of metabolite concentrations during the functional
Fig. 3. Simulation of line-broadening effects on selected metabolite
concentrations quantified by LCModel. Error bars correspond to CRLB.
Estimates of metabolite concentrations were reproducible within the CRLB
of the fit for a line broadening up to 0.5 Hz. A slight tendency in decreasing
the estimated concentrations was observed for NAA, Cr and Glu. Lactate
quantification was nearly unaffected by the tested line-width changes.
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width changes.4. Discussion
In the present study, a 7 T magnetic field was used to
optimize the sensitivity of spectroscopy studies for func-
tional applications. An obvious advantage of ultrahigh
magnetic field is the increased SNR compared to lower
fields, thus making possible to improve the design of
functional protocols in terms of study duration, eventually
with a temporal resolution of few seconds when using
event-related paradigms. Most importantly, the increased
sensitivity at 7 T potentially allows investigating the time
course of metabolites even on single subjects.
A high number of metabolites was investigated at
ultrashort TE, which minimized T2 weighting and J modula-
tion. Moreover, in these experimental conditions, the
measured signal gave information about the concentrationof metabolites in the voxel of interest, even if single-voxel
1H-MRS cannot reach the suitable spatial resolution to
differentiate between cellular compartments, just like any
other modern noninvasive imaging modality.
The reproducibility of the spectra between different
sessions, especially in the region at 1.5 ppm (Fig. 1), demon-
strated high performance of localization. Subcutaneous lipids
from outside the VOI can in fact contaminate the region at
1.5 ppm with broad signals, whose phase can depend on the
distance between the VOI and the lipid-containing tissue
[21]. The flat residual obtained when subtracting spectra
(32 scans average) during stimulation and rest conditions
(Fig. 1) verified a high stability of the system and repro-
ducibility of the measures within each experimental session.
The absence of large peaks in the difference spectra suggested
that possible concentration changes during activation were
within the noise level. The previously reported increases in
lactate of 50% and higher [1,2,5], corresponding to almost
0.5 Amol/g, were not present in the difference spectra when
the voxel was located inside the visual cortex (Fig. 1B).
The sensitivity threshold of single-subject studies can in
general be expressed by the CRLBs, provided that these are
smaller than the intrinsic variations of the measurement
performed in control conditions (voxel outside the visual
cortex). CRLBs are indeed an estimate of the precision
of metabolite concentrations quantified by LCModel.
The sensitivity threshold of our experiment was around
0.1 Amol/g for lactate and 0.2 Amol/g for most of the other
quantified metabolites (Table 1). The analysis of the time
courses of metabolites obtained when the voxel was located
inside the visual cortex indicated that variations of all
metabolites were small, within F0.2 Amol/g (Fig. 2B).
Higher S.D. of lactate compared to CRLB (Table 1)
suggested the possibility of detecting lactate concentration
changes during the functional paradigm in single subjects.
A previous study has reported that the BOLD effect, due
to decreased susceptibility effects resulting from the local
hyper-oxygenation of blood, can alter the T2* of both water
and metabolite signals, introducing a line narrowing of the
spectrum during activation [15]. The observed line narrow-
ing was small (around 0.2–0.3 Hz at 4 T) and discernible
only on the strongest singlets of the spectrum. Differenti-
ating line width from concentration effects is generally not
obvious, but it is still feasible by examining difference
spectra. In fact, subtraction of two peaks with same
frequency, same integral intensity and different line widths
results in a small narrow peak in the difference spectrum,
approximately two times narrower than the characteristic
line width. Any change ascribed to an altered concentration
should instead appear in the difference spectrum as a peak
with the same intrinsic line width. Narrow small peaks, due
to the BOLD effect, were observed in the difference spectra
of our study at 2.0 and 3.0 ppm (Fig. 1B).
In theory, the time courses obtained by deconvolution
algorithms such as the LCModel used here should not
be influenced in a major way by the line narrowing
S. Mangia et al. / Magnetic Resonance Imaging 24 (2006) 343 – 348348introduced by the BOLD effect. Yet, even if LCModel is
to a certain degree able to take into account line-width
changes, small effects on concentration determination
cannot be a priori excluded. Our simulations suggested
that possible functional concentration changes estimated by
LCModel in the order of 1% may be affected by line-width
variations that have not been accounted for. Such effect
can be assessed by analyzing the presence of real concen-
tration effects in the difference between spectra obtained at
rest and during activation with applied appropriate line
broadening in order to deal with line-width changes. The
estimated concentration of lactate was nearly unaffected by
line broadening up to 0.5 Hz, thus ensuring that lactate
changes revealed by LCModel are a robust estimation of
concentration effects.5. Conclusion
We conclude that with the present experimental conditions
functional concentration changes bigger than 0.2 Amol/g
should be detectable at 7 T in single subjects for most
metabolites. Our data also suggested that during prolonged
visual stimuli these changes are within F0.2 Amol/g.
Furthermore, we conclude that minute concentration changes
on the order of a few percentage may be affected by the
BOLD line-narrowing effect.Acknowledgments
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